Literature DB >> 27671881

Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.

Hasan A Zaidi1, David J Cote2, Joseph P Castlen2, William T Burke2, Yong-Hui Liu2, Timothy R Smith2, Edward R Laws2.   

Abstract

BACKGROUND: Primary lactotroph disinhibition, or stalk effect, occurs when mechanical compression of the pituitary stalk disrupts the tonic inhibition by dopamine released by the hypothalamus. The resolution of pituitary stalk effect-related hyperprolactinemia postoperatively has not been studied in a large cohort of patients. We performed a retrospective review to investigate the time course of recovery of lactotroph disinhibition after transsphenoidal surgery.
METHODS: Medical records were retrospectively reviewed for all patients undergoing transsphenoidal surgery with the senior author from April 2008 to November 2014.
RESULTS: Of 556 pituitary adenomas, 289 (52.0%) were eliminated: 77 (13.9%) had an immunohistochemically confirmed prolactinoma, 119 (21.4%) patients had previous surgery, 93 (16.7%) had incomplete medical records, leaving 267 patients (48.0%) for final analysis. Of these patients, 72 (27.0%) had increased serum prolactin levels (≥23.3 ng/mL), suggestive of pituitary stalk effect (maximum prolactin level = 148.0 ng/mL). Patients with stalk effect were more likely than those with normal serum prolactin levels to present with menstrual dysfunction (29.7% vs. 19.4%; P < 0.01) and galactorrhea (11.1% vs. 2.1%; P < 0.01). Patients with lactotroph disinhibition were more likely to harbor macroadenomas than were patients who did not show lactotroph disinhibition (81.9% vs. 70.2%; P = 0.06). Among patients with increased preoperative prolactin, 77.8% experienced normalization of serum prolactin postoperatively, galactorrhea improved in 100%, sexual dysfunction resolved in 66.6%, and menstrual dysfunction among premenopausal females normalized in 73.3% at last follow-up (mean, 5.35 years; range, 0.1-10 years).
CONCLUSIONS: Transsphenoidal surgery can provide durable normalization of serum prolactin levels and related symptoms caused by pituitary stalk compression-related lactotroph disinhibition.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Prolactin; Stalk effect; Transsphenoidal surgery

Mesh:

Substances:

Year:  2016        PMID: 27671881     DOI: 10.1016/j.wneu.2016.09.066

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  8 in total

1.  The extended, transnasal, transsphenoidal approach for anterior skull base meningioma: considerations in patient selection.

Authors:  Joseph P Castlen; David J Cote; Hasan A Zaidi; Edward R Laws
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

2.  Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.

Authors:  David J Cote; John L Kilgallon; Noah L A Nawabi; Hassan Y Dawood; Timothy R Smith; Ursula B Kaiser; Edward R Laws; JoAnn E Manson; Meir J Stampfer
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 3.  Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines.

Authors:  Na Tosha N Gatson; Maria L Boccia; Kerianne R Taylor; Jada K O Mack; Ekokobe Fonkem
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

4.  Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by 18F-FDG and 13N-Ammonia PET/CT.

Authors:  Lei Ding; Fangling Zhang; Qiao He; Zhoulei Li; Xinchong Shi; Ruocheng Li; Xiangsong Zhang
Journal:  BMC Cancer       Date:  2020-06-17       Impact factor: 4.430

Review 5.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

6.  Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.

Authors:  David T Asuzu; Reinier Alvarez; Patrick A Fletcher; Debjani Mandal; Kory Johnson; Weiwei Wu; Abdel Elkahloun; Paul Clavijo; Clint Allen; Dragan Maric; Abhik Ray-Chaudhury; Sharika Rajan; Zied Abdullaev; Diana Nwokoye; Kenneth Aldape; Lynnette K Nieman; Constantine Stratakis; Stanko S Stojilkovic; Prashant Chittiboina
Journal:  Cell Rep       Date:  2022-08-23       Impact factor: 9.995

7.  Full Remission of Long-Term Premenstrual Dysphoric Disorder-Like Symptoms Following Resection of a Pituitary Adenoma: Case Report.

Authors:  Guangrong Lu; Tiana M Shiver; Spiros L Blackburn; William C Yao; Meenakshi B Bhattacharjee; Jay-Jiguang Zhu
Journal:  Am J Case Rep       Date:  2020-08-08

8.  Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study.

Authors:  Liang Lyu; Senlin Yin; Yu Hu; Cheng Chen; Yong Jiang; Yang Yu; Weichao Ma; Zeming Wang; Shu Jiang; Peizhi Zhou
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.